| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review
|
Barhli, Aline
|
|
|
157 |
C |
p.
|
artikel
|
| 2 |
A meta-analysis of CD274 (PD-L1) assessment and prognosis in colorectal cancer and its role in predicting response to anti-PD-1 therapy
|
Alexander, Peter G.
|
|
|
157 |
C |
p.
|
artikel
|
| 3 |
Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy
|
Bouziana, Stella
|
|
|
157 |
C |
p.
|
artikel
|
| 4 |
A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: Utopia or reality?
|
Dalu, Davide
|
|
|
157 |
C |
p.
|
artikel
|
| 5 |
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer
|
Servetto, Alberto
|
|
|
157 |
C |
p.
|
artikel
|
| 6 |
A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma
|
Formica, V.
|
|
|
157 |
C |
p.
|
artikel
|
| 7 |
Biomarkers for predicting the outcome of various cancer immunotherapies
|
Jafarzadeh, Leila
|
|
|
157 |
C |
p.
|
artikel
|
| 8 |
Bleeding with vascular endothelial growth factor tyrosine kinase inhibitor: A network meta-analysis
|
Das, Avash
|
|
|
157 |
C |
p.
|
artikel
|
| 9 |
BRCA1/2 status and chemotherapy response score to tailor ovarian cancer surgery
|
Ponzone, Riccardo
|
|
|
157 |
C |
p.
|
artikel
|
| 10 |
Breast cancer, screening and diagnostic tools: All you need to know
|
Barba, Diego
|
|
|
157 |
C |
p.
|
artikel
|
| 11 |
Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis
|
Buneviciene, Inesa
|
|
|
157 |
C |
p.
|
artikel
|
| 12 |
Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies
|
Michels, Nathalie
|
|
|
157 |
C |
p.
|
artikel
|
| 13 |
Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis
|
Gandini, Sara
|
|
|
157 |
C |
p.
|
artikel
|
| 14 |
Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors
|
Bakkach, Joaira
|
|
|
157 |
C |
p.
|
artikel
|
| 15 |
De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
|
Fedele, Palma
|
|
|
157 |
C |
p.
|
artikel
|
| 16 |
Defining the needs of patients with recurrent and/or metastatic head and neck cancer: An expert opinion
|
Oliveira, Thiago Bueno
|
|
|
157 |
C |
p.
|
artikel
|
| 17 |
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?
|
Colafigli, Gioia
|
|
|
157 |
C |
p.
|
artikel
|
| 18 |
Efficacy and safety of PARP inhibitors in the treatment of advanced ovarian cancer: An updated systematic review and meta-analysis of randomized controlled trials
|
Hao, Jiatao
|
|
|
157 |
C |
p.
|
artikel
|
| 19 |
Efficacy and safety of pembrolizumab based therapies in triple-negative breast cancer: A systematic review of clinical trials
|
Ali, Muhammad Ashar
|
|
|
157 |
C |
p.
|
artikel
|
| 20 |
Efficacy of intravenous NEPA, a fixed NK1/5-HT3 receptor antagonist combination, for the prevention of chemotherapy-induced nausea and vomiting (CINV) during cisplatin- and anthracycline cyclophosphamide (AC)-based chemotherapy: A review of phase 3 studies
|
Aapro, Matti
|
|
|
157 |
C |
p.
|
artikel
|
| 21 |
Exploring the knowledge gap of immune checkpoint inhibitors in chronic renal failure: A systematic review of the literature
|
Mroue, Ahmad
|
|
|
157 |
C |
p.
|
artikel
|
| 22 |
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings
|
Ferro, Matteo
|
|
|
157 |
C |
p.
|
artikel
|
| 23 |
Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles
|
Razavi, Zahra Sadat
|
|
|
157 |
C |
p.
|
artikel
|
| 24 |
Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways
|
Taghiloo, Saeid
|
|
|
157 |
C |
p.
|
artikel
|
| 25 |
Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives
|
Mortezaee, Keywan
|
|
|
157 |
C |
p.
|
artikel
|
| 26 |
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications
|
Pisano, Chiara
|
|
|
157 |
C |
p.
|
artikel
|
| 27 |
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?
|
Lai, Eleonora
|
|
|
157 |
C |
p.
|
artikel
|
| 28 |
Ischemic stroke: A paradoxical manifestation of cancer
|
Salazar-Camelo, Ruth A.
|
|
|
157 |
C |
p.
|
artikel
|
| 29 |
Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?
|
Pons-Tostivint, E.
|
|
|
157 |
C |
p.
|
artikel
|
| 30 |
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave
|
Bertaglia, Valentina
|
|
|
157 |
C |
p.
|
artikel
|
| 31 |
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery
|
Scoccianti, Silvia
|
|
|
157 |
C |
p.
|
artikel
|
| 32 |
Management guidelines for stage III non-small cell lung cancer
|
Jazieh, Abdul Rahman
|
|
|
157 |
C |
p.
|
artikel
|
| 33 |
Management of pain in colorectal cancer patients
|
Zielińska, Anna
|
|
|
157 |
C |
p.
|
artikel
|
| 34 |
Milestones in the treatment of hepatocellular carcinoma: A systematic review.
|
Gryziak, Maciej
|
|
|
157 |
C |
p.
|
artikel
|
| 35 |
miR-26 family and its target genes in tumorigenesis and development
|
Li, Chuangang
|
|
|
157 |
C |
p.
|
artikel
|
| 36 |
miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta‐analysis
|
Mohammadi, Chiman
|
|
|
157 |
C |
p.
|
artikel
|
| 37 |
Molecular landscape of recurrent cervical cancer
|
Adiga, Divya
|
|
|
157 |
C |
p.
|
artikel
|
| 38 |
Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives
|
Imyanitov, Evgeny N.
|
|
|
157 |
C |
p.
|
artikel
|
| 39 |
Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians
|
Houron, Camille
|
|
|
157 |
C |
p.
|
artikel
|
| 40 |
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art
|
Le Saux, Olivia
|
|
|
157 |
C |
p.
|
artikel
|
| 41 |
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives
|
Marinelli, Daniele
|
|
|
157 |
C |
p.
|
artikel
|
| 42 |
Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies
|
Le Compte, Maxim
|
|
|
157 |
C |
p.
|
artikel
|
| 43 |
Post-transplant leukemia relapse in organs: biology. and behavior in 585 reports
|
Cunningham, Isabel
|
|
|
157 |
C |
p.
|
artikel
|
| 44 |
Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants
|
Vuković, Petra
|
|
|
157 |
C |
p.
|
artikel
|
| 45 |
Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review
|
Le Fèvre, Clara
|
|
|
157 |
C |
p.
|
artikel
|
| 46 |
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review
|
Lapidari, Pietro
|
|
|
157 |
C |
p.
|
artikel
|
| 47 |
Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID-19 pandemic
|
Montenegro, Paola
|
|
|
157 |
C |
p.
|
artikel
|
| 48 |
The application of nano-medicine to overcome the challenges related to immune checkpoint blockades in cancer immunotherapy: Recent advances and opportunities
|
Sanaei, Mohammad-Javad
|
|
|
157 |
C |
p.
|
artikel
|
| 49 |
The clinical utility of microsatellite instability in colorectal cancer
|
Diao, Zhenli
|
|
|
157 |
C |
p.
|
artikel
|
| 50 |
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
|
Brighi, Nicole
|
|
|
157 |
C |
p.
|
artikel
|
| 51 |
The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research
|
McKenzie, Nathalie D.
|
|
|
157 |
C |
p.
|
artikel
|
| 52 |
The main sources of circulating cell-free DNA: Apoptosis, necrosis and active secretion
|
Hu, Zijian
|
|
|
157 |
C |
p.
|
artikel
|
| 53 |
Therapeutic potential of p53 reactivation in cervical cancer
|
Zhao, Xiangxuan
|
|
|
157 |
C |
p.
|
artikel
|
| 54 |
Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management
|
Riess, Hanno
|
|
|
157 |
C |
p.
|
artikel
|
| 55 |
Triple negative breast cancer in the era of miRNA
|
Sabit, Hussein
|
|
|
157 |
C |
p.
|
artikel
|
| 56 |
Two sides of the same coin: Insights into the myoepithelial cells in carcinoma ex pleomorphic adenoma development
|
Scarini, João Figueira
|
|
|
157 |
C |
p.
|
artikel
|
Tijdschrift beschrijving